MedPath

To Study Effect Of Navakarshika Guggulu With Apamarga Ksharsutra In Bhagandara

Phase 2/3
Not yet recruiting
Conditions
Anal fistula. Ayurveda Condition: BAGANDARAH,
Registration Number
CTRI/2025/05/086913
Lead Sponsor
R A Podar Ayurvedic Medical College ,Worli
Brief Summary

OBJECTIVE:-

PRIMARY OBJECTIVE –

To evaluate the shodhana property of navakarshika guggulu.

SECONDARY OBJECTIVE –

1 To evaluate the ropanaproperty of navakarshika guggulu*.*

2 To evaluate the analgesic propertyof navakarshikaguggulu.

Approximately 39 subjects per group shouldbe recruited for the trial.

Group A Navakarshika guggulu orally for 4weeks along with Apamarga ksharsutra= 39

Group B Apamarga ksharsutra = 39

 SELECTION OF PATIENT :-

Selection will bemade on chief complaints of patient, past history, history of associated

disease, inspection,palpation, digital examination, proctoscopy an required criteria as per specially designed Performa fulfilling theinclusion criteria is taken for the study.

 ASSESSMENT OF SYMPTOMS :-

Patient will be assess weekly for 8weeks. During each visit UCT will be measure and patient will be questionedregarding the clinical features mentioned in assessment criteria. If fistulatract cut through occur before 8 weeks, then further procedures will be done.

 FOLLOW UP:-

Patient will come for weekly follow upfor 8 weeeks.

ASSESSMENT CRITERIA :-

The study will be strictly based onthe assessment of objective parameters and subjective parameters by gradingthem.

The data obtained will be analyzedstatistically.

OBJECTIVE PARAMETER :-

1.      Unit cutting time –

UCTis derived by following formula = Total no. ofdays for cutting

Initial length of track in cm

2.      Srava –

NoDischarge – 0

Mild(if wound wets 1×1 cm gauze piece) in 24 hour – 1

Moderate(if wound wets 1×1 cm 2 gauze piece) in 24 hour – 2

Severe(if wound wets more than 2 gauze  piece)in 24 hour -3

SUBJECTIVE PARAMETER :-

1.      Pain – pain measure by VAS Scale

CONCLUSION :- The result will be recordedbefore and after treatment and conclusion will be drawn on the basis ofstatistical analysis.

END POINT:-

1.Cutting rate of fistula track will beenhanced with oral administration of navakarshika guggulu.

2.Comparatively healing of fistulatract will be faster with oral administration of navakarshika guggulu.

3.There will be significant reductionin pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
78
Inclusion Criteria
  • 1.Patients with low anal fistula.
  • 2.Irrespective of sex, religion, occupation, economic status and education status.
  • 3.Patients within the age of 20-60yrs.
Exclusion Criteria
  • 1.Patient with high anal fistula.
  • 2.Patients with complex anal fistula.
  • 4.Patient suffering from HIV, HbsAG , any other immunosuppressant Disorders and malignancy will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cutting rate of fistula track will be enhanced with oral administration of navakarshika guggulu8 Weeks
Secondary Outcome Measures
NameTimeMethod
Comparatively healing of fistula tract will be faster with oral administration of navakarshika guggulu8 Weeks
There will be significant reduction in pain8 Weeks

Trial Locations

Locations (1)

M A Podar Hospital

🇮🇳

Mumbai, MAHARASHTRA, India

M A Podar Hospital
🇮🇳Mumbai, MAHARASHTRA, India
Dr Maitri Bhavsar
Principal investigator
9723308290
maitribhavsar18@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.